The San Diego Supercomputer Center (SDSC) at the University of California, San Diego is a partner in a new international collaboration to develop computational models and software for simulations of bifunctional catalysis, which is of high relevance for biomass conversion to liquid fuels and raw materials used in the chemical industry.
On Jan. 23-25, more than 15 stroke survivors and their caregivers will go on a mini-vacation in La Jolla, CA, as part of a therapeutic retreat for those whose lives have been affected – sometimes turned upside down – by stroke. The 50s-themed stroke camp is being co-hosted by UC San Diego Health System, which has one of the nation’s first certified Comprehensive Stroke Centers.
Researchers at University of California, San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences and the Bridge Institute at the University of Southern California report the first crystal structure of the cellular receptor CXCR4 bound to an immune signaling protein called a chemokine. The structure answers longstanding questions about a molecular interaction that plays an important role in human development, immune responses, cancer metastasis and HIV infections.
Upending decades-old dogma, a team of scientists at the University of California, San Diego School of Medicine say enzymes long categorized as promoting cancer are, in fact, tumor suppressors and that current clinical efforts to develop inhibitor-based drugs should instead focus on restoring the enzymes’ activities.
In a surprisingly large chunk of the world, prenatal care looks – or more accurately, sounds – like this: A small, conical wooden tube used to listen to heartbeat of an unborn child.
Researchers at the San Diego Supercomputer Center (SDSC) at the University of California, San Diego, have shown for the first time why protein mutations lead to the familial form of Parkinson’s disease
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
